INSMED INC Net Income (Loss) Available to Common Stockholders, Basic
INSMED INC (INSM) reported Net Income (Loss) Available to Common Stockholders, Basic of -$163.56 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-05-07
- INSMED INC net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$163.56M.
- INSMED INC net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$328.49M.
- INSMED INC net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$370.02M.
- INSMED INC net income (loss) available to common stockholders, basic for the quarter ending 2025-06-30 was -$321.69M.
- INSMED INC net income (loss) available to common stockholders, basic for fiscal 2025 was -$1.28B.
- INSMED INC net income (loss) available to common stockholders, basic for fiscal 2024 was -$913.77M.
- INSMED INC net income (loss) available to common stockholders, basic for fiscal 2023 was -$749.57M.
- INSMED INC net income (loss) available to common stockholders, basic for fiscal 2022 was -$481.53M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$163.56M 10-Q · filed 2026-05-07 | -$492.05M derived: sum of 2 quarters · filed 2026-05-07 | -$862.07M derived: sum of 3 quarters · filed 2026-05-07 | -$1.18B derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | -$328.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$698.51M derived: sum of 2 quarters · filed 2026-02-19 | -$1.02B derived: sum of 3 quarters · filed 2026-02-19 | -$1.28B 10-K · filed 2026-02-19 |
| 2025-09-30 | -$370.02M 10-Q · filed 2025-10-30 | -$691.71M derived: sum of 2 quarters · filed 2025-10-30 | -$948.29M 10-Q · filed 2025-10-30 | -$1.18B derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-06-30 | -$321.69M 10-Q · filed 2025-08-07 | -$578.27M 10-Q · filed 2025-08-07 | -$813.82M derived: sum of 3 quarters · filed 2026-05-07 | -$1.03B derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-03-31 | -$256.58M 10-Q · filed 2026-05-07 | -$492.13M derived: sum of 2 quarters · filed 2026-05-07 | -$712.65M derived: sum of 3 quarters · filed 2026-05-07 | -$1.01B derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$235.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$456.07M derived: sum of 2 quarters · filed 2026-02-19 | -$756.68M derived: sum of 3 quarters · filed 2026-02-19 | -$913.77M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$220.52M 10-Q · filed 2025-10-30 | -$521.13M derived: sum of 2 quarters · filed 2025-10-30 | -$678.22M 10-Q · filed 2025-10-30 | -$864.28M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$300.61M 10-Q · filed 2025-08-07 | -$457.70M 10-Q · filed 2025-08-07 | -$643.76M derived: sum of 3 quarters · filed 2026-02-19 | -$802.69M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$157.09M 10-Q · filed 2025-05-08 | -$343.15M derived: sum of 2 quarters · filed 2026-02-19 | -$502.08M derived: sum of 3 quarters · filed 2026-02-19 | -$746.89M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$186.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$344.99M derived: sum of 2 quarters · filed 2026-02-19 | -$589.80M derived: sum of 3 quarters · filed 2026-02-19 | -$749.57M 10-K · filed 2026-02-19 |
| 2023-09-30 | -$158.93M 10-Q · filed 2024-10-31 | -$403.74M derived: sum of 2 quarters · filed 2024-10-31 | -$563.51M 10-Q · filed 2024-10-31 | -$723.63M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | -$244.81M 10-Q · filed 2024-08-08 | -$404.57M 10-Q · filed 2024-08-08 | -$564.70M derived: sum of 3 quarters · filed 2025-02-20 | -$695.84M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | -$159.76M 10-Q · filed 2024-05-09 | -$319.89M derived: sum of 2 quarters · filed 2025-02-20 | -$451.03M derived: sum of 3 quarters · filed 2025-02-20 | -$546.68M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | -$160.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$291.27M derived: sum of 2 quarters · filed 2025-02-20 | -$386.91M derived: sum of 3 quarters · filed 2025-02-20 | -$481.53M 10-K · filed 2025-02-20 |
| 2022-09-30 | -$131.15M 10-Q · filed 2023-10-26 | -$226.79M derived: sum of 2 quarters · filed 2023-10-26 | -$321.41M 10-Q · filed 2023-10-26 | -$434.39M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$95.64M 10-Q · filed 2023-08-03 | -$190.27M 10-Q · filed 2023-08-03 | -$303.24M derived: sum of 3 quarters · filed 2024-02-22 | -$415.96M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$94.62M 10-Q · filed 2023-05-04 | -$207.60M derived: sum of 2 quarters · filed 2024-02-22 | -$320.31M derived: sum of 3 quarters · filed 2024-02-22 | -$437.63M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$112.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$225.69M derived: sum of 2 quarters · filed 2024-02-22 | -$343.01M derived: sum of 3 quarters · filed 2024-02-22 | -$434.65M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$112.71M 10-Q · filed 2022-10-27 | -$230.03M derived: sum of 2 quarters · filed 2022-10-27 | -$321.68M 10-Q · filed 2022-10-27 | -$423.89M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$117.32M 10-Q · filed 2022-08-04 | -$208.96M 10-Q · filed 2022-08-04 | -$311.18M derived: sum of 3 quarters · filed 2023-02-23 | -$374.83M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$91.64M 10-Q · filed 2022-05-05 | -$193.85M derived: sum of 2 quarters · filed 2023-02-23 | -$257.51M derived: sum of 3 quarters · filed 2023-02-23 | -$319.37M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$102.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$165.87M derived: sum of 2 quarters · filed 2023-02-23 | -$227.73M derived: sum of 3 quarters · filed 2023-02-23 | -$294.09M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$63.66M 10-Q · filed 2021-10-28 | -$125.51M derived: sum of 2 quarters · filed 2021-10-28 | -$191.88M 10-Q · filed 2021-10-28 | -$244.87M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | -$61.85M 10-Q · filed 2021-08-05 | -$128.22M 10-Q · filed 2021-08-05 | -$181.21M derived: sum of 3 quarters · filed 2022-02-17 | -$241.89M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | -$66.36M 10-Q · filed 2021-05-06 | -$119.35M derived: sum of 2 quarters · filed 2022-02-17 | -$180.03M derived: sum of 3 quarters · filed 2022-02-17 | -$246.55M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | -$52.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$113.67M derived: sum of 2 quarters · filed 2022-02-17 | -$180.18M derived: sum of 3 quarters · filed 2022-02-17 | -$254.34M 10-K · filed 2022-02-17 |
| 2019-09-30 | -$60.68M 10-Q · filed 2020-10-29 | -$127.20M derived: sum of 2 quarters · filed 2020-10-29 | -$201.35M 10-Q · filed 2020-10-29 | -$292.92M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$66.51M 10-Q · filed 2020-08-06 | -$140.67M 10-Q · filed 2020-08-06 | -$232.24M derived: sum of 3 quarters · filed 2021-02-25 | -$319.98M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$74.15M 10-Q · filed 2020-04-30 | -$165.73M derived: sum of 2 quarters · filed 2021-02-25 | -$253.47M derived: sum of 3 quarters · filed 2021-02-25 | -$329.91M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$91.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$179.32M derived: sum of 2 quarters · filed 2021-02-25 | -$255.75M derived: sum of 3 quarters · filed 2021-02-25 | -$324.28M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$87.74M 10-Q · filed 2019-10-30 | -$164.18M derived: sum of 2 quarters · filed 2019-10-30 | -$232.70M 10-Q · filed 2019-10-30 | -$298.09M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$76.44M 10-Q · filed 2019-08-01 | -$144.96M 10-Q · filed 2019-08-01 | -$210.34M derived: sum of 3 quarters · filed 2020-02-25 | -$255.52M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$68.52M 10-Q · filed 2019-05-07 | -$133.91M derived: sum of 2 quarters · filed 2020-02-25 | -$179.09M derived: sum of 3 quarters · filed 2020-02-25 | -$223.76M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | -$65.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$110.56M derived: sum of 2 quarters · filed 2020-02-25 | -$155.24M derived: sum of 3 quarters · filed 2020-02-25 | -$192.65M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$45.18M 10-Q · filed 2017-11-02 | -$89.85M derived: sum of 2 quarters · filed 2017-11-02 | -$127.27M 10-Q · filed 2017-11-02 | -$195.67M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | -$44.67M 10-Q · filed 2017-08-03 | -$82.09M 10-Q · filed 2017-08-03 | -$150.49M derived: sum of 3 quarters · filed 2019-02-22 | -$188.25M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | -$37.41M 10-Q · filed 2018-05-02 | -$105.82M derived: sum of 2 quarters · filed 2019-02-22 | -$143.58M derived: sum of 3 quarters · filed 2019-02-22 | -$180.16M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | -$68.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$106.16M derived: sum of 2 quarters · filed 2019-02-22 | -$142.74M derived: sum of 3 quarters · filed 2019-02-22 | -$176.27M 10-K · filed 2019-02-22 |
| 2016-09-30 | -$37.76M 10-Q · filed 2017-11-02 | -$74.34M derived: sum of 2 quarters · filed 2017-11-02 | -$107.87M 10-Q · filed 2017-11-02 | -$139.12M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | -$36.58M 10-Q · filed 2017-08-03 | -$70.11M 10-Q · filed 2017-08-03 | -$101.36M derived: sum of 3 quarters · filed 2018-02-23 | -$132.32M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | -$33.53M 10-Q · filed 2017-05-03 | -$64.78M derived: sum of 2 quarters · filed 2018-02-23 | -$95.74M derived: sum of 3 quarters · filed 2018-02-23 | -$124.35M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | -$31.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$62.21M derived: sum of 2 quarters · filed 2018-02-23 | -$90.81M derived: sum of 3 quarters · filed 2018-02-23 | -$118.18M 10-K · filed 2018-02-23 |
| 2015-09-30 | -$30.96M 10-Q · filed 2016-11-03 | -$59.57M derived: sum of 2 quarters · filed 2016-11-03 | -$86.94M 10-Q · filed 2016-11-03 | -$104.58M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | -$28.61M 10-Q · filed 2016-08-04 | -$55.98M 10-Q · filed 2016-08-04 | -$73.62M derived: sum of 3 quarters · filed 2017-02-23 | -$97.61M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | -$27.37M 10-Q · filed 2016-05-05 | -$45.02M derived: sum of 2 quarters · filed 2017-02-23 | -$69.01M derived: sum of 3 quarters · filed 2017-02-23 | -$92.23M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | -$17.65M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$41.64M derived: sum of 2 quarters · filed 2017-02-23 | -$64.86M derived: sum of 3 quarters · filed 2017-02-23 | -$79.16M 10-K · filed 2017-02-23 |
| 2014-09-30 | -$23.99M 10-Q · filed 2015-11-06 | -$47.21M derived: sum of 2 quarters · filed 2015-11-06 | -$61.51M 10-Q · filed 2015-11-06 | -$77.73M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | -$23.22M 10-Q · filed 2015-08-06 | -$37.52M 10-Q · filed 2015-08-06 | -$53.74M derived: sum of 3 quarters · filed 2016-02-25 | -$71.06M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$14.30M 10-Q · filed 2015-05-07 | -$30.51M derived: sum of 2 quarters · filed 2016-02-25 | -$47.84M derived: sum of 3 quarters · filed 2016-02-25 | -$56.69M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$16.21M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$33.54M derived: sum of 2 quarters · filed 2016-02-25 | -$42.40M derived: sum of 3 quarters · filed 2016-02-25 | -$56.07M 10-K · filed 2016-02-25 |
| 2013-09-30 | -$17.33M 10-Q · filed 2014-11-06 | -$26.18M derived: sum of 2 quarters · filed 2014-11-06 | -$39.86M 10-Q · filed 2014-11-06 | -$55.31M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | -$8.85M 10-Q · filed 2014-08-06 | -$22.53M 10-Q · filed 2014-08-06 | -$37.98M derived: sum of 3 quarters · filed 2015-02-27 | -$47.37M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | -$13.68M 10-Q · filed 2014-05-08 | -$29.13M derived: sum of 2 quarters · filed 2015-02-27 | -$38.51M derived: sum of 3 quarters · filed 2015-02-27 | -$48.21M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | -$15.45M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$24.83M derived: sum of 2 quarters · filed 2015-02-27 | -$34.53M derived: sum of 3 quarters · filed 2015-02-27 | -$41.37M 10-K · filed 2015-02-27 |
| 2012-09-30 | -$9.38M 10-Q · filed 2013-11-05 | -$19.08M derived: sum of 2 quarters · filed 2013-11-05 | -$25.92M 10-Q · filed 2013-11-05 | -$34.09M derived: sum of 4 quarters · filed 2014-03-06 |
| 2012-06-30 | -$9.70M 10-Q · filed 2013-08-06 | -$16.54M 10-Q · filed 2013-08-06 | -$24.70M derived: sum of 3 quarters · filed 2014-03-06 | -$59.29M derived: sum of 4 quarters · filed 2014-03-06 |
| 2012-03-31 | -$6.84M 10-Q · filed 2013-05-07 | -$15.01M derived: sum of 2 quarters · filed 2014-03-06 | -$49.60M derived: sum of 3 quarters · filed 2014-03-06 | -$59.62M derived: sum of 4 quarters · filed 2014-03-06 |
| 2011-12-31 | -$8.16M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | -$42.75M derived: sum of 2 quarters · filed 2014-03-06 | -$52.77M derived: sum of 3 quarters · filed 2014-03-06 | -$68.84M 10-K · filed 2014-03-06 |
| 2011-09-30 | -$34.59M 10-Q · filed 2012-11-07 | -$44.61M derived: sum of 2 quarters · filed 2012-11-07 | -$60.68M 10-Q · filed 2012-11-07 | -$66.52M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$10.02M 10-Q · filed 2012-08-07 | -$26.09M 10-Q · filed 2012-08-07 | -$31.93M derived: sum of 3 quarters · filed 2013-03-18 | -$32.26M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | -$16.07M 10-Q · filed 2012-05-08 | -$21.91M derived: sum of 2 quarters · filed 2013-03-18 | -$22.24M derived: sum of 3 quarters · filed 2013-03-18 | -$22.62M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | -$5.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$6.17M derived: sum of 2 quarters · filed 2013-03-18 | -$6.55M derived: sum of 3 quarters · filed 2013-03-18 | -$6.43M 10-K · filed 2013-03-18 |
| 2010-09-30 | -$330.00K 10-Q · filed 2011-11-09 | -$708.00K derived: sum of 2 quarters · filed 2011-11-09 | -$590.00K 10-Q · filed 2011-11-09 | |
| 2010-06-30 | -$378.00K 10-Q/A · filed 2011-08-08 | -$260.00K 10-Q/A · filed 2011-08-08 | ||
| 2009-12-31 | $118.35M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |